Dezhou Honghai Pharmaceutical Technology Co., Ltd, was established in 2023 and is located in the Science and Technology Innovation and Entrepreneurship Park of Yucheng City, Dezhou City, Shandong Province. The company has a registered capital of 2 million yuan, and the laboratory and R&D center covers an area of 1,600 square meters. It has more than 30 employees, including more than 20 middle and senior management and technical personnel.

The company is mainly engaged in the research, development and industrialization of key pharmaceutical intermediates such as antibacterial and anti-tumor generic drugs and new drugs. It mainly focuses on the preparation, development and technical services of drug intermediates and active small molecule inhibitors. It has professional R&D capabilities and rich experience in pharmaceutical R&D and declaration. At present, the company has more than a dozen types of medicines and pharmaceutical intermediates, all of which have been mass-produced. The company has a R&D team composed of senior doctoral professors and senior engineers from Shandong First Medical University, Shandong Normal University, etc.

The company is equipped with a full range of analytical testing equipment, including Waters e2695, Shimadzu UV detection liquid phase LC-2010C, Agilent gas phase 6890, polarimeter, melting point meter and other detectors, equipped with 1-5000L reactors of different types and materials to meet different reaction needs.